- Home
- CING vs PLRZ Comparison
CING vs PLRZ Comparison
Compare CING & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CING
- PLRZ
- Stock Information
- Founded
- CING 2012
- PLRZ 2005
- Country
- CING United States
- PLRZ Israel
- Employees
- CING N/A
- PLRZ N/A
- Industry
- CING Biotechnology: Pharmaceutical Preparations
- PLRZ
- Sector
- CING Health Care
- PLRZ
- Exchange
- CING Nasdaq
- PLRZ NYSE
- Market Cap
- CING 13.1M
- PLRZ 14.7M
- IPO Year
- CING 2021
- PLRZ 2024
- Fundamental
- Price
- CING $4.33
- PLRZ $0.33
- Analyst Decision
- CING Strong Buy
- PLRZ
- Analyst Count
- CING 4
- PLRZ 0
- Target Price
- CING $30.67
- PLRZ N/A
- AVG Volume (30 Days)
- CING 97.0K
- PLRZ 290.7K
- Earning Date
- CING 05-07-2025
- PLRZ 02-15-2025
- Dividend Yield
- CING N/A
- PLRZ N/A
- EPS Growth
- CING N/A
- PLRZ N/A
- EPS
- CING N/A
- PLRZ N/A
- Revenue
- CING N/A
- PLRZ N/A
- Revenue This Year
- CING N/A
- PLRZ N/A
- Revenue Next Year
- CING N/A
- PLRZ N/A
- P/E Ratio
- CING N/A
- PLRZ N/A
- Revenue Growth
- CING N/A
- PLRZ N/A
- 52 Week Low
- CING $1.80
- PLRZ $0.28
- 52 Week High
- CING $20.83
- PLRZ $4.80
- Technical
- Relative Strength Index (RSI)
- CING 57.77
- PLRZ N/A
- Support Level
- CING $4.03
- PLRZ N/A
- Resistance Level
- CING $4.44
- PLRZ N/A
- Average True Range (ATR)
- CING 0.29
- PLRZ 0.00
- MACD
- CING 0.04
- PLRZ 0.00
- Stochastic Oscillator
- CING 74.38
- PLRZ 0.00
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.